Search Within

Tao Dao

Refine Results
Formats
  1. Journal Article (32)
  2. Meeting Abstract (26)
Groups
  1. Sloan Kettering Institute Postdocs (58)
  2. Hematologic Oncology, Division of (55)
  3. Center for Hematologic Malignancies (54)
  4. Sloan Kettering Institute Faculty (52)
  5. Adult Leukemia (51)
  6. Hematologic Malignancies Research (51)

More Groups

People
  1. David Scheinberg (51)
  2. Tatyana Korontsvit (26)
  3. Viktoriya Zakhaleva (25)
  4. Dmitry Pankov (11)
  5. Leonid Dubrovsky (11)
  6. Peter Maslak (11)

More People

Years
  1. 2018 (3)
  2. 2017 (4)
  3. 2016 (5)
  4. 2015 (4)
  5. 2014 (3)
  6. 2013 (8)

More Years

Publications
  1. Blood (22)
  2. Clinical Cancer Research (5)
  3. OncoImmunology (4)
  4. Journal of Clinical Oncology (3)
  5. Clinical Lymphoma, Myeloma and Leukemia (2)
  6. Expert Opinion on Biological Therapy (2)

More Publications

Publishers
  1. American Society of Hematology (23)
  2. American Association for Cancer Research (6)
  3. Landes Bioscience (4)
  4. Nature Publishing Group (4)
  5. American Society of Clinical Oncology (3)
  6. Elsevier Inc. (3)

More Publishers

Results (58)

Export to EndNote | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Epigenetic drug treatment induces presentation of new class of non-exonic cryptic neoantigens in acute myeloid leukemia cells
    Meeting Abstract

    Klatt, M. G.; Mun, S. S.; Socci, N. D.; Korontsvit, T.; Dao, T.; Scheinberg, D. A.
    Blood (2018)

    Fulltext@MSK | Save
  • Improved sensitivity and specificity for mutated and unmutated class I HLA ligand identifications lead to better immunotherapy target discovery
    Meeting Abstract

    Klatt, M.; Gejman, R.; Mun, S. S.; Dao, T.; Scheinberg, D.
    Clinical Lymphoma, Myeloma and Leukemia (2018)

    Fulltext@MSK | Save
  • Phase 2 trial of a multivalent WT1 peptide vaccine (galinpepimut-S) in acute myeloid leukemia
    Journal Article

    Maslak, P. G.; Dao, T.; Bernal, Y.; Chanel, S. M.; Zhang, R.; Frattini, M.; Rosenblat, T.; Jurcic, J. G.; Brentjens, R. J.; Arcila, M. E.; more...
    Blood Advances (2018)

    Fulltext@MSK | Save
  • A randomized phase II trial of adjuvant galinpepimut-S, WT-1 analogue peptide vaccine, after multimodality therapy for patients with malignant pleural mesothelioma
    Journal Article

    Zauderer, M. G.; Tsao, A. S.; Dao, T.; Panageas, K.; Lai, W. V.; Rimner, A.; Rusch, V. W.; Adusumilli, P. S.; Ginsberg, M. S.; Gomez, D.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • Optimized T-cell receptor-mimic chimeric antigen receptor T cells directed toward the intracellular Wilms Tumor 1 antigen
    Journal Article

    Rafiq, S.; Purdon, T. J.; Daniyan, A. F.; Koneru, M.; Dao, T.; Liu, C.; Scheinberg, D. A.; Brentjens, R. J.
    Leukemia (2017)

    Fulltext@MSK | Save
  • A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens
    Journal Article

    Chang, A. Y.; Dao, T.; Gejman, R. S.; Jarvis, C. A.; Scott, A.; Dubrovsky, L.; Mathias, M. D.; Korontsvit, T.; Zakhaleva, V.; Curcio, M.; more...
    Journal of Clinical Investigation (2017)

    Fulltext@MSK | Save
  • An immunogenic WT1-derived peptide that induces T cell response in the context of HLA-A*02:01 and HLA-A*24:02 molecules
    Journal Article

    Dao, T.; Korontsvit, T.; Zakhaleva, V.; Jarvis, C.; Mondello, P.; Oh, C.; Scheinberg, D. A.
    OncoImmunology (2017)

    Fulltext@MSK | Save
  • Mechanisms of leukemia resistance to antibody dependent cellular cytotoxicity
    Journal Article

    Dubrovsky, L.; Brea, E. J.; Pankov, D.; Casey, E.; Dao, T.; Liu, C.; Scheinberg, D. A.
    OncoImmunology (2016)

    Fulltext@MSK | Save
  • Opportunities and challenges for TCR mimic antibodies in cancer therapy
    Journal Article

    Chang, A. Y.; Gejman, R. S.; Brea, E. J.; Oh, C. Y.; Mathias, M. D.; Pankov, D.; Casey, E.; Dao, T.; Scheinberg, D. A.
    Expert Opinion on Biological Therapy (2016)

    Fulltext@MSK | Save
  • Potent therapeutic and immunological effects of the first T-BiTE derived from a TCR-mimic antibody targeting intracellular oncoprotein WT1
    Meeting Abstract

    Dao, T.; Pankov, D.; Scott, A.; Korontsvit, T.; Zakhaleva, V.; Direito de Morais Guerreiro, M.; Xu, Y. Y.; Xiang, J. Y.; Yan, S.; Veomett, N.; more...
    Cancer Immunology Research (2016)

    Fulltext@MSK | Save